SCHEMBL807973

SCHEMBL807973

CC(C)(N)c1ccc(-c2nnc3cnc4ccc(-c5ccc(N)nc5)cc4n23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 12/20 0.41
NPBWR1 P48145 2/20 0.40
PRKDC P78527 11/20 0.40
PIK3CB P42338 9/20 0.40
ATR Q13535 9/20 0.40
ATRIP Q8WXE1 8/20 0.40
MTOR P42345 6/20 0.38
SERPINA2 P20848 4/20 0.38
BRD4 O60885 1/20 0.37
MAP4K4 O95819 1/20 0.37
CYP3A4 P08684 1/20 0.37
PIK3CD O00329 2/20 0.36
PIK3CA P42336 2/20 0.36
PIK3C2A O00443 1/20 0.36
PIK3C2B O00750 1/20 0.36
PIK3R1 P27986 1/20 0.36
PIK3CG P48736 1/20 0.36
RPTOR Q8N122 1/20 0.36
PIK3C3 Q8NEB9 1/20 0.36
MLST8 Q9BVC4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15131796 0.87 MTOR (0.49) ATMNPBWR1PRKDCPIK3CBATR
SCHEMBL807975 0.85 PRKDC (0.44) ATMPRKDCPIK3CBATRATRIP
SCHEMBL10070634 0.83 MAPT (0.41) ATMPRKDCPIK3CBATRATRIP
SCHEMBL807837 0.81 PRKDC (0.38) ATMPRKDCPIK3CBATRATRIP
SCHEMBL807987 0.80 GSK3B (0.38) ATMPRKDCPIK3CBATRATRIP
SCHEMBL807839 0.77 PRKDC (0.43) ATMPRKDCPIK3CBATRATRIP
SCHEMBL15131811 0.76 MTOR (0.38) ATMPRKDCPIK3CBATRATRIP
SCHEMBL15131800 0.75 PIK3CB (0.42) ATMPRKDCPIK3CBATRATRIP
SCHEMBL807817 0.74 PI4KA (0.52) PIK3CBPIK3CDPIK3CAPIK3CGPI4KB
SCHEMBL15133610 0.74 PIK3CB (0.41) ATMPRKDCPIK3CBATRATRIP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012034526-A1 FUSED HETEROARYLS AND THEIR USES HUTCHISON MEDIPHARMA LIMITED (CN) 2012-03-22 WO disclosed